Curable Inc

NEW
XKRX:086460 (Korea (the Republic of))  
â‚© 1,454 (0%) Mar 28
At Loss
P/B:
0.36
Market Cap:
â‚© 4.25B ($ 2.89M)
Enterprise V:
â‚© 14.05B ($ 9.56M)
Volume:
-
Avg Vol (2M):
944.00
Trade In:
What is a stock summary page? Click here for an overview.

Business Description

Description
Curable Inc provides genome analysis service.
Name Current Vs Industry Vs History
Cash-To-Debt 0.02
Equity-to-Asset 0.48
Debt-to-Equity 0.84
Debt-to-EBITDA -1.71
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -1.05
Distress
Grey
Safe
Beneish M-Score -4.29
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.35
Quick Ratio 0.35
Cash Ratio 0.02
Days Sales Outstanding 63.58
Days Payable 575.05

Dividend & Buy Back

Name Current Vs Industry Vs History
Shareholder Yield % -182.53

Profitability Rank

Name Current Vs Industry Vs History
Gross Margin % 60.46
Operating Margin % -2857.77
Net Margin % -3689.15
FCF Margin % -2957.86
ROE % -58.7
ROA % -30.44
ROIC % -23.72
ROC (Joel Greenblatt) % -83
ROCE % -42.17

GF Value Rank

Name Current Vs Industry Vs History
PS Ratio 19.83
PB Ratio 0.36
Price-to-Tangible-Book 0.36
EV-to-EBIT -1.9
EV-to-EBITDA -2.41
EV-to-Revenue 66.37
EV-to-FCF -2.24
Earnings Yield (Greenblatt) % -52.63
FCF Yield % -147.4
Income Statement Breakdown FY
Not Enough Data
Balance Sheet Breakdown
Not Enough Data
Cashflow Statement Breakdown
Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
Not Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016

Curable Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil â‚©) 211.7
EPS (TTM) (â‚©) -2705
Beta -0.16
3-Year Sharpe Ratio -0.36
3-Year Sortino Ratio -0.47
Volatility % 107.07
14-Day RSI 54.89
14-Day ATR (â‚©) 88.806303
20-Day SMA (â‚©) 1331.35
12-1 Month Momentum % -76.29
52-Week Range (â‚©) 454 - 8240
Shares Outstanding (Mil) 2.92

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Curable Inc Filings

Filing Date Document Date Form
No Filing Data

Curable Inc Stock Events

Financials Calendars
Event Date Price (â‚©)
No Event Data

Curable Inc Frequently Asked Questions

What is Curable Inc(XKRX:086460)'s stock price today?
The current price of XKRX:086460 is â‚©1454.00. The 52 week high of XKRX:086460 is â‚©8240.00 and 52 week low is â‚©454.00.
When is next earnings date of Curable Inc(XKRX:086460)?
The next earnings date of Curable Inc(XKRX:086460) is .
Does Curable Inc(XKRX:086460) pay dividends? If so, how much?
Curable Inc(XKRX:086460) does not pay dividend.

Press Release

Subject Date
No Press Release